Eyeing the Indian healthcare market,
Germany-based Beurer GmbH
recently launched many health and
well-being products.
The products include Bluetooth-
enabled sleep sensor, digital blood
pressure monitors, digital BMI
weighing scales and mobile ECG
device. The 98-year-old company has
already introduced 60-70 products,
out of its vast range of over 400
products, in major Indian cities such
as Bengaluru, Delhi, Mumbai, and
Ahmedabad in the past two years.
Stanley Joseph, Group General
Manager, H.W Int’l, L.L.C Dubai,
sole distributor in Gulf region and
India for Beurer GmbH Germany
said, “With the Beurer products,
users can transform their homes into
mini-clinic, as it eliminates the need
for them to go to hospitals for basic
health check-ups such as checking
their blood pressure levels.”Bio-Iron supplement, launched by Sami Direct, is a naturally-sourced, iron-enriched
and clinically-evaluated bioavailable iron, which is safe and effective as its main
ingredient is rich and natural source of iron
Iron deficiency anaemia (IDA) is the most commonly prevalent type of anaemia
worldwide, including India. While it affects all age groups, the most vulnerable
sections are children, pregnant women and non-pregnant women of child-bearing
age. Bio-Iron is sourced from green gram (moong) ― a natural source of iron.
Diets low in vegetables, and high in “sugar-sweetened and diet soft drinks,
refined sugars and carbohydrates, processed meats, and junk food” have been linked
to IDA.
Iron is an essential trace mineral found in every cell and is vital for both the
physical as well as the mental well-being. It is estimated that 70 per cent of the
body’s iron is found in the red blood cells and myoglobin in muscles. IDA is caused
when your body does not have enough iron to produce haemoglobin. Haemoglobin
enables the red blood cells to carry oxygenated blood throughout the body.Bio-Iron is latest supplement from Sami Direct
Eli Lilly India launch Humalog
200U/mL KwikPenTM
Beurer GmbH next-
gen healthcare
products for India
Eli Lilly and Company (India)
Pvt. Ltd., launched Humalog®
200U/mL KwikPenTM (insulin
lispro 200U/mL), a pre-filled
pen containing a concentrated
formulation of Lilly’s rapid-
acting insulin Humalog®
(insulin lispro).
Over time, some patients
may require dosage increase for
improved glycemic control. This
also leads to increase in number
of pens being used. Humalog®
200 U/mL KwikPenTM offers
physicians an alternative that
allows patients to inject 50
per cent less insulin volume.
Often the transition to a
more intensified mealtime
insulin therapy is difficult for
patients. Humalog® 200 U/
mL KwikPenTM is another
option that may help make
mealtime insulin therapy more
convenient.
Edgard Olaizola, Managing
Director, Eli Lilly and Company
(India) Pvt. Ltd. said, “Patients
may require dosage increase
over time for better glycemic
control. Humalog® 200U/
mL KwikPenTM provides
physicians a new prescription
option for their patients. Fewer
pen changes per month may
help people who require higher
daily doses of mealtime insulin
making it a convenient option
for patients who lead busy lives.
Lilly is committed to bringing
innovative products to India.”
Tarun Puri, Medical
Director, Eli Lilly & Company
(India) Pvt. Ltd. said, “Since
1923, the needs of patients
have continually inspired Lilly
to innovate and introduce
strategies for better outcomes.
While efficacy and safety are
critical, simplicity and ease of
use are just as important.”http://www.biospectrumindia.com | May 2017 | BioSpectrum l SUPPLIER NEWS^15